1. Home
  2. GPCR vs GEL Comparison

GPCR vs GEL Comparison

Compare GPCR & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • GEL
  • Stock Information
  • Founded
  • GPCR 2016
  • GEL 1996
  • Country
  • GPCR United States
  • GEL United States
  • Employees
  • GPCR N/A
  • GEL N/A
  • Industry
  • GPCR
  • GEL Oil Refining/Marketing
  • Sector
  • GPCR
  • GEL Energy
  • Exchange
  • GPCR Nasdaq
  • GEL Nasdaq
  • Market Cap
  • GPCR 1.8B
  • GEL 1.4B
  • IPO Year
  • GPCR 2023
  • GEL 1996
  • Fundamental
  • Price
  • GPCR $27.30
  • GEL $10.48
  • Analyst Decision
  • GPCR Buy
  • GEL Buy
  • Analyst Count
  • GPCR 6
  • GEL 2
  • Target Price
  • GPCR $85.67
  • GEL $16.00
  • AVG Volume (30 Days)
  • GPCR 797.2K
  • GEL 393.7K
  • Earning Date
  • GPCR 11-13-2024
  • GEL 02-13-2025
  • Dividend Yield
  • GPCR N/A
  • GEL 6.38%
  • EPS Growth
  • GPCR N/A
  • GEL N/A
  • EPS
  • GPCR N/A
  • GEL N/A
  • Revenue
  • GPCR N/A
  • GEL $3,014,767,000.00
  • Revenue This Year
  • GPCR N/A
  • GEL N/A
  • Revenue Next Year
  • GPCR N/A
  • GEL $0.97
  • P/E Ratio
  • GPCR N/A
  • GEL N/A
  • Revenue Growth
  • GPCR N/A
  • GEL N/A
  • 52 Week Low
  • GPCR $29.48
  • GEL $10.01
  • 52 Week High
  • GPCR $62.74
  • GEL $15.17
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.94
  • GEL 31.77
  • Support Level
  • GPCR $30.81
  • GEL $10.18
  • Resistance Level
  • GPCR $36.42
  • GEL $11.27
  • Average True Range (ATR)
  • GPCR 2.10
  • GEL 0.34
  • MACD
  • GPCR -0.15
  • GEL -0.08
  • Stochastic Oscillator
  • GPCR 25.07
  • GEL 12.09

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: